e-learning
resources
Paris 2018
Tuesday, 18.09.2018
COPD and extrapulmonary comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD: CT Thorax - friend or foe’: Clinical utility of CT in diagnosing co-morbidities.
A. Vohra (London, United Kingdom), S. Raza (London , United Kingdom), P. Dalal (London, United Kingdom), S. Kaul (London , United Kingdom)
Source:
International Congress 2018 – COPD and extrapulmonary comorbidities
Session:
COPD and extrapulmonary comorbidities
Session type:
Thematic Poster
Number:
4032
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Vohra (London, United Kingdom), S. Raza (London , United Kingdom), P. Dalal (London, United Kingdom), S. Kaul (London , United Kingdom). COPD: CT Thorax - friend or foe’: Clinical utility of CT in diagnosing co-morbidities.. 4032
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
HRCT evaluation of thoracic sarcoidosis: What is the use?
Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Year: 2010
Radiology in pleural disease: what is the role of chest radiographs, CT and PET in modern management?
Source: Eur Respir Monogr 2020; 87: 48-72
Year: 2020
Do chest computed tomography and radiography influence clinical management in children with cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Late Breaking Abstract - Associations between a COPD genetic risk score and lung structure on computed tomography (CT): SPIROMICS
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018
Value of routine chest radiograph on diagnosis of COPD. Is it valuable?
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010
LATE-BREAKING ABSTRACT: Comparative studies on bronchuswall-thickness by histologic and computed tomographic measurements of porcine lungs
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Chest computed tomography: is it ready for major studies of chronic obstructive pulmonary disease?
Source: Eur Respir J 2001; 17: 1062-1064
Year: 2001
Thoracic high resolution computed tomography may be helpful in the differentiation between the patients with chronic obstructive pulmonary disease and the smoking patients with asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Computed tomography for evaluation of the small airway disease in asthma
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
The incremintal value of chest computed tomography on chest radiographs in the diagnosis of pneumonia in bedridden patients
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Emphysema and respiratory bronchiolitis (RB) on high resolution computed tomography of the thorax (HRCT) in smokers with normal spirometry
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Determination of mild emphysema on computed tomography and chest X-ray
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?
Source: Eur Respir J 2013; 42: 844-857
Year: 2013
Computerised tomography (CT) – Gold standard for structural lung disease in young children with CT?
Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Year: 2012
CTPA: the right diagnosis the wrong way?
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009
Evidence-based diagnostic algorithms for pulmonary embolism: why are they necessary?
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=165
Year: 2004
Haemoptysis with normal chest x-ray: Do all patients require CT chest and bronchoscopy?
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Relation of high resolution computed tomography findings with functional parameters in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Managing COVID-19 illness: chest radiographs support defining both prognosis and follow up.
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - The prognostic value of computed tomography findings in COVID-19 older patients
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept